The role of endothelin in coronary atherosclerosis

Mayo Clinic Proceedings

Volumn 71, Issue 8, 1996, Pages 769-777

  Mathew, Verghese ^a   Hasdai, David ^a   Lerman, Amir ^a  

^a MAYO CLINIC ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; ENDOTHELIN; ENDOTHELIUM DERIVED RELAXING FACTOR; LOW DENSITY LIPOPROTEIN; PLATELET DERIVED GROWTH FACTOR; VASOACTIVE AGENT;

ATHEROGENESIS; BLOOD VESSEL INJURY; CELL ACTIVITY; CELL INTERACTION; CELL PROLIFERATION; CHEMOTAXIS; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY RISK; DISEASE ASSOCIATION; HUMAN; MITOGENESIS; MORPHOLOGY; PATHOGENESIS; REVIEW; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0030317635     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-6196(11)64842-8     Document Type: Article

References (76)

1. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (first of two parts). N Engl J Med 1992; 326:242-250
2. Ip JH, Fuster V, Badimon L, Badimon J, Taubman MB, Chesebro JH. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am CollCardiol 1990; 15:1667-1687
3. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362:801-809
4. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332:411-415
5. Lerman A, Hildebrand FL Jr, Margulies KB, O'Murchu B, Perrella MA, Heublein DM, et al. Endothelin: a new cardio-vascular regulatory peptide. MayoClinProc 1990; 65:14411455
6. Liischer TF, Oemar BS, Boulanger CM, Hahn AWA. Molecular and cellular biology of endothelin and its receptors. Parti. Part II. J Hypertens 1993; 11:7-11; 121-126
7. Haynes WG, Webb DJ. Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet 1994; 344:852-854
8. Hirata Y, Emori T, Eguchi S, Kanno K, Imai T, Ohta K, et al. Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells. J Clin Invest 1993;91:1367-1373
9. Seo B, Oemar BS, Siebenmann R, von Segesser L, Luscher TF. Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. Circulation 1994; 89:1203-1208
10. Rigel DF, Lappe RW. Differential responsiveness of conduit and resistance coronary arteries to endothelin A and B receptor stimulation in anesthetized dogs. J Cardiovasc Pharmacol 1993;22(Suppl8):S243-S247
11. Haller H, Schaberg T, Lindschau C, Lode H, Distler A. Endothelin increases [Ca2+]., protein phosphorylation, and O~production in human alveolar macrophages. Am J Physiol 1991;261:L478-L484
12. Boulanger CM, Tanner FC, Bea ML, Hahn AW, Werner A, Luscher TF. Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium. Circ Res 1992; 70:1191-1197
13. Moncada S. Higgs EA, editors. Nitric oxide from L-arginine: a bioregulatory system. Excerpta Medica International Congress Series No. 897, 1990
14. Weber H. Webb ML, Serafino R, Taylor DS, Moreland S, Norman J, et al. Endothelin-1 and angiotensin-II stimulate delayed mitogenesis in cultured rat aortic smooth muscle cells: evidence for common signaling mechanisms. Mol Endocrinol 1994; 8:148-158
15. Sjolund M, Hedin U, Sejersen T, Heldin CH, Thyberg J. Arterial smooth muscle cells express platelet-derived growth factor (PDGF) A chain mRNA, secrete a PDGF-like mitogen, and bind exogenous PDGF in a phenotype- and growth statedependent manner. JCellBiol 1988;106:403-413
16. Weissberg PL, Witchell C, Davenport AP, Hesketh TR, Metcalfe JC. The endothelin peptides ET-1, ET-2, ET-3 and sarafotoxin S6b are co-mitogenic with platelet-derived growth factor for vascular smooth muscle cells. Atherosclerosis 1990; 85:257-262
17. Resink TJ, Hahn AW, Scott-Burden T, Powell J, Weber E, Bühler FR. Inducible endothelin mRNA expression and peptide secretion in cultured human vascular smooth muscle cells. Biochem Biophys Res Commun 1990; 168:13031310
18. Alberts GF, Peifley KA, Johns A, Kleha JF, Winkles JA. Constitutive endothelin-1 overexpression promotes smooth muscle cell proliferation via an external autocrine loop. J BiolChem 1994; 269:10112-10118
19. Douglas SA, Louden C, Vickery-Clark LM, Storer BL, Hart T, Feuerstein GZ, et al. A role for endogenous endothelin-1 in neointimal formation after rat carotid artery balloon angioplasty: protective effects of the novel nonpeptide endothelin receptor antagonist SB 209670. Circ Res 1994; 75:190197
20. Douglas SA, Ohlstein EH. Endothelin-1 promotes neointima formation after balloon angioplasty in the rat. J Cardiovasc Pharmacol 1993; 22(Suppl 8):S371-S373
21. Lonchampt MO, Pinelis S, Goulin J, Chabrier PE, Braquet P. Proliferation and Na+/H+ exchange activation by endothelin in vascular smooth muscle cells. Am J Hypertens 1991; 4:776-779
22. Kanse SM, Wijelath E, Kanthou C, Newman P, Kakkar VV. The proliferative responsiveness of human vascular smooth muscle cells to endothelin correlates with endothelin receptor density. Lab Invest 1995; 72:376-382
23. Kowala MC, Rose PM, Stein PD, Goller N, Recce R, Beyer S, et al. Selective blockade of the endothelin subtype A receptor decreases early atherosclerosis in hamsters fed cholesterol. AmJPathol 1995; 146:819-826
24. Serradeil-Le Gal C, Herbert JM, Garcia C, Boutin M, Maffrand JP. Importance of the phenotypic state of vascular smooth muscle cells on the binding and the mitogenic activity of endothelin. Peptides 1991; 12:575-579
25. SeniorRM, Huang JS, Griffin GL, DeuelTF. Dissociation of the chemotactic and mitogenic activities of platelet-derived growth factor by human neutrophil elastase. J Cell Biol 1985; 100:351-356
26. Peacock AJ, Dawes KE, Shock A, Gray AJ, Reeves JT, Laurent GJ. Endothelin-1 and endothelin-3 induce chemotaxis and replication of pulmonary artery fibroblasts. Am J Respir Cell Mol Biol 1992; 7:492-499
27. Kikuchi K, Kadono T, Sato S, Tamaki K, Takehara K. Impaired growth response to endothelin-1 in scleroderma fibroblasts. Biochem Biophys Res Commun 1995; 207:829-838
28. Fant ME, Nanu L, Word RA. A potential role for endothelin1 in human placental growth: interactions with the insulinlike growth factor family of peptides. J Clin Endocrinol Metab 1992; 74:1158-1163
29. Yeh YC, Burns ER, Yeh J, Yeh HW. Synergistic effects of endothelin-1 (ET-1) and transforming growth factor alpha (TGF-alpha) or epidermal growth factor (EGF) on DNA replication and Gl to S phase transition. Biosci Rep 1991; 11:171-180
30. Guidry C, Hook M. Endothelins produced by endothelial cells promote collagen gel contraction by fibroblasts. J Cell Biol 1991; 115:873-880
31. Halim A, Kanayama N, el Maradny E, Maehara K, Terao T. Coagulation in vivo microcirculation and in vitro caused by endothelin-1. ThrombRes 1993; 72:203-209
32. Leadley RJ Jr, Lee P, Erickson LA, Shebuski RJ. The snake venom peptide sarafotoxin S6b inhibits repetitive platelet thrombus formation in the stenosed canine coronary artery. J Cardiovasc Pharmacol 1993; 22(Suppl 8):S199-S203
33. McMurdoL, Lidbury PS,ThiemermannC, Vane JR. Mediation of endothelin-1-induced inhibition of platelet aggregation via the ETB receptor. Br J Pharmacol 1993; 109:530534
34. Cannan CR, Burnett JC Jr, Brandt RR, Lerman A. Endothelin at pathophysiological concentrations mediates coronary vasoconstriction via the endothelin-A receptor. Circulation 1995; 92:3312-3317
35. Martin-Nizard F, Houssaini HS, Lestavel-Delattre S, Duriez P, Fruchart JC. Modified low density lipoproteins activate human macrophages to secrete immunoreactive endothelin. FEES Lett 1991; 293:127-130
36. Horio T, Kohno M, Murakawa K, Yasunari K, Yokokawa K, Ueda M, et al. Increased plasma immunoreactive endothelin1 concentration in hypercholesterolemic rats. Atherosclerosis 1991; 89:239-246
37. Lerman A, Webster MW, Chesebro JH, Edwards WD, Wei CM, Fuster V, et al. Circulating and tissue endothelin immunoreactivity in hypercholesterolemic pigs. Circulation 1993; 88:2923-2928
38. Haak T, März W, Jungmann E, Hausser S, Siekmeier R, Gross W, et al. Elevated endothelin levels in patients with hyperlipoproteinemia. Clin Invest 1994; 72:580-584
39. Lerman A, Edwards BS, Halle JW, Heublein DM, Sandberg SM, Burnett JC Jr. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 1991; 325:997-1001
40. Haak T, Jungmann E, Raab C, Usadel KH. Elevated endothelin-1 levels after cigarette smoking. Metabolism 1994; 43:267-269
41. Kiowski W, Linder L, Stoschitzky K, Pfisterer M, Burckhardt D, Burkart F, et al. Diminished vascular response to inhibition of endothelium-derived nitric oxide and enhanced vasoconstriction to exogenously administered endothelin-1 in clinically healthy smokers. Circulation 1994; 90:27-34
42. Schiffrin EL. Endothelin in hypertension. Curr Opin Cardiol 1995; 10:485-494
43. Lerman A, Burnett JC Jr. Intact and altered endothelium in regulation of vasomotion. Circulation 1992; 86(Suppl 3):III12-III19
44. Flavahan NA. Atherosclerosis or lipoprotein-induced endothelial dysfunction: potential mechanisms underlying reduction in EDRF/nitric oxide activity. Circulation 1992; 85:1927-1938
45. Zeiher AM, Drexler H, Saurbier B, Just H. Endotheliummediated coronary blood flow modulation in humans: effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest 1993; 92:652-662
46. Cannan CR, McGoon M, Holmes DR Jr, Lerman A. Altered coronary endothelial function in a patient with asymptomatic left ventricular dysfunction. Int J Cardiol 1996; 53:147151
47. Lerman A, Holmes DR Jr, Bell MR, Garratt KN, Nishimura RA, Burnett JC Jr. Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. Circulation 1995; 92:2426-2431
48. Yasuda M, Kohno M, Tahara A, Itagane H, Toda I, Akioka K, et al. Circulating immunoreactive endothelin in ischémie heart disease. Am Heart J 1990; 119:801-806
49. Ray SG, McMurray JJ, Morton JJ, Dargie HJ. Circulating endothelin in acute ischaemic syndromes. Br Heart J 1992; 67:383-386
50. Zeiher AM, Goebel H, Schachinger V, Ihling C. Tissue endothelin-1 immunoreactivity in the active coronary atherosclerotic plaque: a clue to the mechanism of increased vasoreactivity of the culprit lesion in unstable angina. Circulation 1995; 91:941-947
51. Toyo-oka T, Aizawa T, Suzuki N, Hirata Y, Miyauchi T, Shin WS, et al. Increased plasma level of endothelin-1 and coronary spasm induction in patients with vasospastic angina pectoris. Circulation 1991; 83:476-483
52. Bogaty P, Hackett D, Davies G, Maseri A. Vasoreactivity of the culprit lesion in unstable angina. Circulation 1994; 90:511
53. Miyauchi T, Yanagisawa M, Tomizawa T, Sugishita Y, Suzuki N, Fujino M, et al. Increased plasma concentrations of endothelin-1 and big endothelin-1 in acute myocardial infarction [letter]. Lancet 1989; 2:53-54
54. Nakamura M, Arakawa N, Yoshida H, Funakoshi T, Chiba M, Abe Y, et al. Increased plasma endothelin concentrations in patients with acute heart failure after myocardial infarction. Jpn Cire J 1993; 57:371-378
55. Omland T, Lie RT, Aakvaag A, Aarsland T, Dickstein K. Plasma endothelin determination as a prognostic indicator of 1 -year mortality after acute myocardial infarction. Circulation 1994;89:1573-1579
56. Watanabe T, Suzuki N, Shimamoto N, Fujino M, Imada A. Contribution of endogenous endothelin to the extension of myocardial infarct size in rats. Circ Res 1991; 69:370377
57. Grover GJ, Dzwonczyk S, Parham CS. The endothelin-1 receptor antagonist BQ-123 reduces infarct size in a canine model of coronary occlusion and reperfusion. Cardiovasc Res 1993; 27:1613-1618
58. Velasco CE, Turner M, Inagami T, Atkinson JB, Virmani R, Jackson EK, et al. Reperfusion enhances the local release of endothelin after regional myocardial ischemia. Am Heart J 1994; 128:441-451
59. Margulies KB, Hildebrand FL Jr, Lerman A, Perrella MA, Burnett JC Jr. Increased endothelin in experimental heart failure. Circulation 1990; 82:2226-2230
60. Kourembanas S, Marsden PA, McQuillan LP, Faller DV. Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J Clin Invest 1991; 88:10541057
61. Yoshizumi M, Kurihara H, Sugiyama T, Takaku F, Yanagisawa M, Masaki T, et al. Hemodynamic shear stress stimulates endothelin production by cultured endothelial cells. Biochem Biophys Res Commun 1989; 161:859864
62. Pearson PJ, Lin PJ, Schaff HV. Global myocardial ischemia and reperfusion impair endothelium-dependent relaxations to aggregating platelets in the canine coronary artery: a possible cause of vasospasm following cardiopulmonary bypass. J Thorac Cardiovasc Surg 1992; 103:1147-1154
63. Lerman A, Mruk JS, Webster MWI, Burnett JC Jr, Chesebro JH. Activation of endothelin during arterial thrombosis and thrombolysis [abstract]. J Am Coll Cardiol 1991; 17(Suppl A):26A
64. Boulanger CM, Luscher TF. Hirudin and nitrates inhibit the thrombin-induced release of endothelin from the intact porcine aorta. CircRes 1991; 68:1768-1772
65. Gruntzig AR, Senning A, Siegenthaler WE. Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med 1979; 301:61-68
66. Tahara A, Kohno M, Yanagi S, Itagane H, Toda I, Akioka K, et al. Circulating immunoreactive endothelin in patients undergoing percutaneous transluminal coronary angioplasty. Metabolism 1991; 40:1235-1237
67. Lerman A, Holmes DR Jr, Garratt KN, Reeder GS, Bell MR, Burnett JC Jr. Local release of endothelin in human coronary arteries in response to balloon angioplasty [abstract]. J Am Coll Cardiol 1994; 23(Special Issue): 124A
68. Harrison VJ, Barnes K, Turner AJ, Wood E, Corder R, Vane JR. Identification of endothelin 1 and big endothelin 1 in secretory vesicles isolated from bovine aortic endothelial cells. Proc Natl Acad Sei U S A 1995; 92:6344-6348
69. Douglas SA, Vickery-Clark LM, Louden C, Ohlstein EH. Selective ETA receptor antagonism with BQ-123 is insufficient to inhibit angioplasty induced neointima formation in the rat. Cardiovasc Res 1995; 29:641-646
70. Azuma H, Hamasaki H, Niimi Y. Endothelin-1 (ET-1 ) plays a role in the intimai hyperplasia after endothelial removal [abstract]. Can J Physiol Pharmacol 1994; 72(Suppl 1): 154
71. Clavell A, Stingo A, Margulies K, Lerman A, Underwood D, Burnett JC Jr. Physiological significance of endothelin: its role in congestive heart failure. Circulation 1993; 87(Suppl 5):V45-V50
72. Wei CM, Lerman A, Rodeheffer RJ, McGregor CGA, Brandt RR, Wright S, et al. Endothelin in human congestive heart failure. Circulation 1994; 89:1580-1586
73. Rodeheffer RJ, Lerman A, Heublein DM, Burnett JC Jr. Increased plasma concentrations of endothelin in congestive heart failure in humans. Mayo Clin Proc 1992; 67:719-724
74. Kiowski W, Sutsch G, Hunziker P, Muller P, Kim J, Oechslin E, et al. Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure. Lancet 1995; 346:732736
75. Lerman A, Kubo SH, Tschumperlin LK, Burnett JC Jr. Plasma endothelin concentrations in humans with end-stage heart failure and after cardiac transplantation. J Am Coll Cardiol 1992; 20:849-853
76. Berkenboom G, Giot C, Linger P, Vachiery JL, Antoine M, LeClerc JL. Plasma endothelin and early coronary endothelial dysfunction in recipients of a cardiac transplant. Am Heart J 1995; 129:1178-1184